#biotechnology
#biotechnology

Pets

This Pill Promises to Give Your Dog More Years. You Might Not Like What Comes With Them.

Pet owners prioritize their pets' health, with many willing to incur debt for their care.

A company named Loyal is developing drugs aimed at extending dogs' healthy lifespan.

Digital life

The Centuries-Old, Incredibly Male Quest to Live Forever

The longevity industry is experiencing unprecedented growth, reflecting a societal obsession with extending human life significantly beyond current limits.

Growth hacking

fromEntrepreneur

1 day ago

This Gene Therapy Startup Wants to Change the Way We Age | Entrepreneur

Minicircle aims to slow aging and enhance biological function through a quick gene therapy injection.

fromSlate Magazine

Pets

This Pill Promises to Give Your Dog More Years. You Might Not Like What Comes With Them.

Pet owners prioritize their pets' health, with many willing to incur debt for their care.

A company named Loyal is developing drugs aimed at extending dogs' healthy lifespan.

Digital life

The Centuries-Old, Incredibly Male Quest to Live Forever

The longevity industry is experiencing unprecedented growth, reflecting a societal obsession with extending human life significantly beyond current limits.

These States Are Driving 21st Century Technology Faster Than the Rest

California and Massachusetts remain key players in technological innovation, with a focus on AI and biotech respectively.

2 days ago

OMG science

Opinion | The White House Tech Bros Owe Their Fortunes to the Research They're Killing

University research is essential for America's entrepreneurial culture and technological advancements.

Tech industry

These States Are Driving 21st Century Technology Faster Than the Rest

California and Massachusetts remain key players in technological innovation, with a focus on AI and biotech respectively.

2 days ago

OMG science

Opinion | The White House Tech Bros Owe Their Fortunes to the Research They're Killing

University research is essential for America's entrepreneurial culture and technological advancements.

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

4Tissue has secured €1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.

Artificial intelligence

French firm Bioptimus bags 74M - Silicon Canals

Bioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.

Marketing tech

In other news this week: Granite Bio emerges from stealth with 87.6M, Didomi bags 72M, First Momentum Ventures closes 35M, and more - Silicon Canals

Significant funding rounds highlight emerging biotech and tech companies, showcasing innovation in addressing critical needs across multiple sectors.

Startup companies

Amsterdam's Avidicure exits stealth mode with 43.8M to develop new antibody therapies - Silicon Canals

Avidicure launched with $50M funding to develop multifunctional antibodies for cancer treatment, aiming to revolutionize oncology with innovative therapies.

Startup companies

Leuven-based Augustine Therapeutics raises 77.7M to advance neuromuscular drug development - Silicon Canals

Augustine Therapeutics raises €77.7M for CMT disease treatment, marking a significant step in innovative therapeutics for neurodegenerative conditions.

European startups

Barcelona's KOA Biotech reels in 2M

KOA Biotech secures €2M funding to advance aquaculture technology.

Investment focuses on addressing environmental impact and food security.

The company's biosensor system targets early detection of fish farm infections.

European startups

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

4Tissue has secured €1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.

Artificial intelligence

French firm Bioptimus bags 74M - Silicon Canals

Bioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.

Marketing tech

In other news this week: Granite Bio emerges from stealth with 87.6M, Didomi bags 72M, First Momentum Ventures closes 35M, and more - Silicon Canals

Significant funding rounds highlight emerging biotech and tech companies, showcasing innovation in addressing critical needs across multiple sectors.

Startup companies

Amsterdam's Avidicure exits stealth mode with 43.8M to develop new antibody therapies - Silicon Canals

Avidicure launched with $50M funding to develop multifunctional antibodies for cancer treatment, aiming to revolutionize oncology with innovative therapies.

Startup companies

Leuven-based Augustine Therapeutics raises 77.7M to advance neuromuscular drug development - Silicon Canals

Augustine Therapeutics raises €77.7M for CMT disease treatment, marking a significant step in innovative therapeutics for neurodegenerative conditions.

European startups

Barcelona's KOA Biotech reels in 2M

KOA Biotech secures €2M funding to advance aquaculture technology.

Investment focuses on addressing environmental impact and food security.

The company's biosensor system targets early detection of fish farm infections.

It's time to hit the reset button on GMOs

GMO 2.0 is set to revolutionize agriculture with innovative technologies aiding sustainability and efficiency, addressing global food demand.

US news

A cell pulls off one of the 'Holy Grails' of biotechnology

A groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.

fromIPWatchdog.com | Patents & Intellectual Property Law

Green Innovation in Brazil: How Patent Protection Is Powering Sustainable Agriculture

Brazil is poised to lead in agricultural biological agents due to its biodiversity and climate.

Growth hacking

Lab-grown chicken nuggets' hailed as transformative step' for cultured meat

Breakthrough in lab-grown meat achieved with bioreactor technology that mimics blood vessels, supporting larger chunks of chicken meat.

This innovation could revolutionize lab-grown meat production and organ growth.

fromMail Online

5 days ago

OMG science

Scientists using fossilised collagen to create T.Rex LEATHER

T.Rex leather is a new sustainable luxury material engineered from fossil DNA.

This innovative material combines genomic engineering and advanced tissue engineering.

It's time to hit the reset button on GMOs

GMO 2.0 is set to revolutionize agriculture with innovative technologies aiding sustainability and efficiency, addressing global food demand.

US news

A cell pulls off one of the 'Holy Grails' of biotechnology

A groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.

fromIPWatchdog.com | Patents & Intellectual Property Law

Green Innovation in Brazil: How Patent Protection Is Powering Sustainable Agriculture

Brazil is poised to lead in agricultural biological agents due to its biodiversity and climate.

Growth hacking

Lab-grown chicken nuggets' hailed as transformative step' for cultured meat

Breakthrough in lab-grown meat achieved with bioreactor technology that mimics blood vessels, supporting larger chunks of chicken meat.

This innovation could revolutionize lab-grown meat production and organ growth.

fromMail Online

5 days ago

OMG science

Scientists using fossilised collagen to create T.Rex LEATHER

T.Rex leather is a new sustainable luxury material engineered from fossil DNA.

This innovative material combines genomic engineering and advanced tissue engineering.

Fertility startup 'rejuvenates' human eggs to boost chances of conception

Ovo Labs is developing technologies to enhance IVF success rates by rejuvenating human eggs, aiming to lower genetic errors and increase conception chances.

Four rising stars at the forefront of cancer research

Young researchers are innovating in cancer drug development, focusing on pioneering techniques like cancer reversion to reduce the need for traditional treatments.

Cancer

What's in a Name: Cure51 Co-founder Nicolas Wolikow on honouring Rosalind Franklin and one of the most important photos ever taken - Silicon Canals

Cure51 aims to revolutionize oncology by creating the first global database of cancer survivors and seeking new treatments based on survivor data.

Cancer

Four rising stars at the forefront of cancer research

Young researchers are innovating in cancer drug development, focusing on pioneering techniques like cancer reversion to reduce the need for traditional treatments.

Cancer

What's in a Name: Cure51 Co-founder Nicolas Wolikow on honouring Rosalind Franklin and one of the most important photos ever taken - Silicon Canals

Cure51 aims to revolutionize oncology by creating the first global database of cancer survivors and seeking new treatments based on survivor data.

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

Colossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.

NYC startup

fromBusiness Insider

A startup plans to make money from reviving the woolly mammoth. Here's how.

Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.

fromInsideHook

Have Scientists Created Hybrids of Mice and Mammoths?

Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.

fromwww.scientificamerican.com

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.

Scientists aiming to bring back woolly mammoth create woolly mice

Scientists create genetically modified woolly mice as a step toward reviving woolly mammoths.

These scientists are trying to revive woolly mammoths ... by modifying mice

Colossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

Colossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.

NYC startup

fromBusiness Insider

A startup plans to make money from reviving the woolly mammoth. Here's how.

Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.

fromInsideHook

Have Scientists Created Hybrids of Mice and Mammoths?

Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.

fromwww.scientificamerican.com

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.

Scientists aiming to bring back woolly mammoth create woolly mice

Scientists create genetically modified woolly mice as a step toward reviving woolly mammoths.

These scientists are trying to revive woolly mammoths ... by modifying mice

Colossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.

Microbes in Brooklyn superfund site teach lessons on fighting industrial pollution

Microorganisms in Gowanus Canal have developed extensive pollution-fighting genes, offering potential for sustainable waterway cleanup.

UK & US-based healthtech startup Level Zero Health bags 6.63M

Level Zero Health has secured £5.5M in pre-seed funding to develop continuous hormone monitoring technology using DNA-based sensors.

3 weeks ago

European startups

Dutch healthtech startups that raised funding in 2025

Dutch startups gained €3.1B in 2025, reflecting a confident innovation ecosystem and notable growth in healthtech.

Fundraising

UK & US-based healthtech startup Level Zero Health bags 6.63M

Level Zero Health has secured £5.5M in pre-seed funding to develop continuous hormone monitoring technology using DNA-based sensors.

3 weeks ago

European startups

Dutch healthtech startups that raised funding in 2025

Dutch startups gained €3.1B in 2025, reflecting a confident innovation ecosystem and notable growth in healthtech.

Journal targeted by paper mill still grappling with the aftermath years later

Despite claims of addressing the issue, Bioengineered still contains hundreds of dubious papers linked to paper mills.

Mental health

fromBig Think

3 weeks ago

The next era of psychedelics may be precision-designed states of consciousness

Mindstate Design Labs aims to create predictable psychedelic experiences for improved mental health treatment.

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

Bluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.

fromWIRED

This Blood Vessel Was Grown in a Lab With Real Human Cells

Humacyte has developed a bioengineered blood vessel to help avoid amputation in patients with vascular trauma.

Alternative medicine

FDA approves siRNA drug for haemophilia prophylaxis

Fitusiran has received FDA approval for hemophilia prophylaxis, with a dosing schedule that enhances convenience for patients.

fromwww.mercurynews.com

SF food

Tiny Silicon Valley drugmaker soars on FDA win to treat never-ending hunger

Soleno Therapeutics' Vykat XR receives FDA approval for treating insatiable hunger linked to Prader-Willi syndrome, boosting stock significantly.

Venture

fromMedCity News

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

Bluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.

fromWIRED

This Blood Vessel Was Grown in a Lab With Real Human Cells

Humacyte has developed a bioengineered blood vessel to help avoid amputation in patients with vascular trauma.

Alternative medicine

FDA approves siRNA drug for haemophilia prophylaxis

Fitusiran has received FDA approval for hemophilia prophylaxis, with a dosing schedule that enhances convenience for patients.

fromwww.mercurynews.com

SF food

Tiny Silicon Valley drugmaker soars on FDA win to treat never-ending hunger

Soleno Therapeutics' Vykat XR receives FDA approval for treating insatiable hunger linked to Prader-Willi syndrome, boosting stock significantly.

more#fda-approval

#23andme

fromThe Washington Post

23andMe thought its DNA data would help research. Then reality hit.

23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.

CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.

Privacy professionals

fromTheregister

Genetic data sharing service openSNP to close down

OpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.

23andMe Is Selling All Your Data, in Largest Sale of Genomes in History

23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.

fromThe Washington Post

23andMe thought its DNA data would help research. Then reality hit.

23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.

CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.

Privacy professionals

fromTheregister

Genetic data sharing service openSNP to close down

OpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.

23andMe Is Selling All Your Data, in Largest Sale of Genomes in History

23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.

Tech firms are cashing in on the bizarre science of organ preservation

The evolution of organ transplantation technology is creating new business opportunities.

OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.

Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.

fromBerlin Art Link

OMG science

Emilia Tikka Studio Visit | Berlin Art Link

Emilia Tikka explores the intersection of cultural history and biotechnology, addressing societal implications through her art and research.

European startups

fromTNW | Deep-Tech

Tech firms are cashing in on the bizarre science of organ preservation

The evolution of organ transplantation technology is creating new business opportunities.

OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.

Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.

fromBerlin Art Link

OMG science

Emilia Tikka Studio Visit | Berlin Art Link

Emilia Tikka explores the intersection of cultural history and biotechnology, addressing societal implications through her art and research.

FDA-Approved Artificial Blood Vessel Stirs Concerns

FDA approved Humacyte's lab-grown blood vessels despite serious patient complications, raising concerns about study validation and patient safety.

#sustainable-agriculture

SF food

Gene-edited non-browning banana could cut food waste, scientists say

The genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.

NYC startup

The most innovative companies in agriculture for 2025

Innovative agriculture companies are focusing on sustainable practices to ensure future farming and food production.

Miscellaneous

EIB backs GreenLight Biosciences with 35M loan to replace traditional chemical pesticides using power of RNA - Silicon Canals

GreenLight Biosciences España secures €35M loan from EIB to advance RNA-based agricultural solutions.

SF food

Gene-edited non-browning banana could cut food waste, scientists say

The genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.

NYC startup

The most innovative companies in agriculture for 2025

Innovative agriculture companies are focusing on sustainable practices to ensure future farming and food production.

more#sustainable-agriculture

Miscellaneous

EIB backs GreenLight Biosciences with 35M loan to replace traditional chemical pesticides using power of RNA - Silicon Canals

GreenLight Biosciences España secures €35M loan from EIB to advance RNA-based agricultural solutions.

#artificial-intelligence

Artificial intelligence

Four ways to power-up AI for drug discovery

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

These 10 biotech companies are changing how we discover new drugs and treat complex diseases

Biotech companies are harnessing AI and cutting-edge research tools to enhance drug development and diagnostics.

fromPsychology Today

Artificial intelligence

Are Human Neurons AI's Future?

The development of 'wetware' technology could revolutionize artificial intelligence by utilizing biological neurons instead of traditional silicon chips.

Design

Scientists use AI to design life-like enzymes from scratch

AI can design novel enzymes that perform multi-step reactions effectively, revolutionizing enzyme engineering.

Artificial intelligence

Four ways to power-up AI for drug discovery

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

These 10 biotech companies are changing how we discover new drugs and treat complex diseases

Biotech companies are harnessing AI and cutting-edge research tools to enhance drug development and diagnostics.

Artificial intelligence

fromPsychology Today

Are Human Neurons AI's Future?

The development of 'wetware' technology could revolutionize artificial intelligence by utilizing biological neurons instead of traditional silicon chips.

more#artificial-intelligence

Design

Scientists use AI to design life-like enzymes from scratch

AI can design novel enzymes that perform multi-step reactions effectively, revolutionizing enzyme engineering.

Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longer

Tech billionaires are investing heavily in longevity research, turning life-extending therapeutics into a burgeoning $25 billion industry.

Silicon Valley food

For Patients Needing Transplants, Hope Arrives on Tiny Hooves

Cloned pigs are being raised in controlled conditions for potential use in human organ transplants, highlighting advances in biotechnology and ethical considerations.

Miscellaneous

fromNew York Post

Exclusive | Behind the billionaire-backed longevity business - and the innovations that could help us live longer

Tech billionaires are investing heavily in longevity research, turning life-extending therapeutics into a burgeoning $25 billion industry.

Silicon Valley food

For Patients Needing Transplants, Hope Arrives on Tiny Hooves

Cloned pigs are being raised in controlled conditions for potential use in human organ transplants, highlighting advances in biotechnology and ethical considerations.

'Startup Nation' Groups Say They're Meeting Trump Officials to Push for Deregulated 'Freedom Cities'

Regulatory challenges hinder technological development despite available capital and political support.

#antibiotic-resistance

fromHarvard Gazette

Harvard startup creating a new class of antibiotics - Harvard Gazette

Kinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.

fromCornell Chronicle

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

Transposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.

fromHarvard Gazette

Harvard startup creating a new class of antibiotics - Harvard Gazette

Kinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.

fromCornell Chronicle

more#antibiotic-resistance

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

Transposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.

Coronavirus

fromCornell Chronicle

COVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle

A new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.

The Billionaire Baker Brothers Just Made This Big Biotech Stock Move

Billionaires Julian and Felix Baker significantly influence biotech investments through their hedge fund, Baker Bros. Advisors.

Medicine

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.

Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.

Venture

The Billionaire Baker Brothers Just Made This Big Biotech Stock Move

Billionaires Julian and Felix Baker significantly influence biotech investments through their hedge fund, Baker Bros. Advisors.

Medicine

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.

Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

Afynia Laboratories aims to revolutionize endometriosis diagnosis with a novel blood test utilizing microRNA biomarkers.

NYC startup

Bold red lipstick gets its color from crushed bugs. This biotech startup made a version that's insect-free

The classic red color of lipstick traditionally comes from carmine, but a new biotech alternative has emerged without using insects.

Silicon Valley

US court upholds Theranos founder Elizabeth Holmes's conviction

Elizabeth Holmes's conviction for defrauding investors in Theranos is upheld by a U.S. court, rejecting her appeal against the ruling.

Why is it so hard to rewrite a genome?

Synthetic genomics has progressed significantly since the failed Big DNA Contest in 2004, demonstrating the importance of ambition and imagination in research.

Miscellaneous

This MIT spinout wants to spool hair-thin fibers into patients' brains | TechCrunch

NeuroBionics seeks to revolutionize treatment for neurological conditions through minimally invasive neuromodulation therapies using advanced materials.

Miscellaneous

Scientist Testing Spider-Man-Style Web Shooters He Accidentally Made in Lab

Researchers created a new adhesive inspired by nature that mimics Spider-Man's web-shooting abilities.

The discovery of a material that can remotely capture objects opens new possibilities in biotechnology.

Medicine

Why is it so hard to rewrite a genome?

Synthetic genomics has progressed significantly since the failed Big DNA Contest in 2004, demonstrating the importance of ambition and imagination in research.

Miscellaneous

This MIT spinout wants to spool hair-thin fibers into patients' brains | TechCrunch

NeuroBionics seeks to revolutionize treatment for neurological conditions through minimally invasive neuromodulation therapies using advanced materials.

Miscellaneous

Scientist Testing Spider-Man-Style Web Shooters He Accidentally Made in Lab

Researchers created a new adhesive inspired by nature that mimics Spider-Man's web-shooting abilities.

The discovery of a material that can remotely capture objects opens new possibilities in biotechnology.

Artificial intelligence

Deepmind scientist raises $50m to use AI in protein design revolution

Latent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.

Miscellaneous

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunch

Latent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.

fromAlleywatch

NYC startup

The Weekly Notable Startup Funding Report: 1/13/25

Notable startup funding in various sectors totaled $1.3B, showcasing innovation and investment across multiple industries, including biotechnology and healthcare.

fromBusiness Matters

Artificial intelligence

Deepmind scientist raises $50m to use AI in protein design revolution

Latent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.

Miscellaneous

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunch

Latent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.

fromAlleywatch

NYC startup

The Weekly Notable Startup Funding Report: 1/13/25

Notable startup funding in various sectors totaled $1.3B, showcasing innovation and investment across multiple industries, including biotechnology and healthcare.

AI used to design a multi-step enzyme that can digest some plastics

The enzyme design process improved significantly with PLACER screening, resulting in enzymes that could perform multiple reactions.

#intellectual-property

fromPatently-O

fromIPWatchdog.com | Patents & Intellectual Property Law

Business

Federal Circuit Upholds ITC Import Ban: Key Rulings on Storage Defense and Domestic Industry Requirements

The Federal Circuit supported Ventria's patent rights against Wuhan Healthgen's importation of infringing products, reinforcing protection for small biotech companies.

Intellectual property law

Other Barks & Bites for Friday, February 7: CAFC Rejects Untimely Expert Testimony and Reassigns Case; CJEU Clarifies Online Marketplace Responsibilities Under GDPR; and IPWATCHPUPPIES ARE ON THE WAY!

The article discusses important developments in intellectual property law, showcasing recent rulings and trends affecting both the U.S. and European landscapes.

fromPatently-O

fromIPWatchdog.com | Patents & Intellectual Property Law

Business

Federal Circuit Upholds ITC Import Ban: Key Rulings on Storage Defense and Domestic Industry Requirements

The Federal Circuit supported Ventria's patent rights against Wuhan Healthgen's importation of infringing products, reinforcing protection for small biotech companies.

more#intellectual-property

Intellectual property law

Other Barks & Bites for Friday, February 7: CAFC Rejects Untimely Expert Testimony and Reassigns Case; CJEU Clarifies Online Marketplace Responsibilities Under GDPR; and IPWATCHPUPPIES ARE ON THE WAY!

The article discusses important developments in intellectual property law, showcasing recent rulings and trends affecting both the U.S. and European landscapes.

#genetic-engineering

Male mosquitoes to be genetically engineered to poison females with semen in Australian research

Genetically engineered male mosquitoes can inject venom into females during mating to reduce mosquito populations and disease transmission.

Medicine

Surgeons Transplant Engineered Pig Kidney Into Fourth Patient

Successful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.

Male mosquitoes to be genetically engineered to poison females with semen in Australian research

Genetically engineered male mosquitoes can inject venom into females during mating to reduce mosquito populations and disease transmission.

Medicine

Surgeons Transplant Engineered Pig Kidney Into Fourth Patient

Successful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.

more#genetic-engineering

Business intelligence

fromBusiness Matters

Leen Kawas on Resilience as Strategy: The Role of Female Leadership in Transformative Change

Women in leadership roles bring unique perspectives that enhance organizational transformation through adaptability and emotional intelligence.

fromBusiness Matters

Medicine

Growth Hormone Therapy Market Set to Double by 2032 - Here's Why

The growth hormone therapy market is rapidly expanding due to technological advancements and increased consumer demand.

Groundbreaking': scientists develop patch that can repair damaged hearts

Researchers have developed implantable patches to treat heart failure using laboratory-grown heart muscle, offering new hope for patients.

The patches made from reprogrammed blood cells are a breakthrough in biological transplants for heart conditions.

fromPatently-O

Intellectual property law

Federal Circuit (Again) Upholds Ravgen's Fetal DNA cffDNA Patent

The Federal Circuit upheld the validity of Ravgen's fetal DNA testing patent and clarified standing requirements for appealing IPR decisions.

Digital life

Ramaswamy Has a High-Profile Perch and a Raft of Potential Conflicts

Ramaswamy's financial interests present potential conflicts as he influences federal policies.

fromInverse

Microbes can colonize space, produce drugs and create energy researchers are simulating their inner workings to harness how

Researchers are digitally recreating microbial processes to more efficiently produce useful chemicals for various industries.